Cannabidiol modulates the expression of alzheimer’s disease-related genes in mesenchymal stem cells

International Journal of Molecular Sciences

Volumn 18, Issue 1, 2017, Pages

  Libro, Rosaliana ^a   Diomede, Francesca ^b   Scionti, Domenico ^a   Piattelli, Adriano ^b   Grassi, Gianpaolo ^c   Pollastro, Federica ^d   Bramanti, Placido ^a   Mazzon, Emanuela ^a   Trubiani, Oriana ^b  

^a IRCCS CENTRO NEUROLESI BONINO PULEJO   (Italy)

^b UNIVERSITY OF CHIETI   (Italy)

^c CRA Experimental Institute for Industrial Crops   (Italy)

^d UNIVERSITY OF EASTERN PIEDMONT   (Italy)

Author keywords

Alzheimer s disease; Amyloid beta; Cannabidiol; Glycogen synthase kinase 3 ; Mesenchymal stem cells; Tau

Indexed keywords

AMYLOID BETA PROTEIN; CANNABIDIOL; CANNABINOID RECEPTOR; GLYCOGEN SYNTHASE KINASE 3BETA; HEAT SHOCK PROTEIN; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN KINASE B; RIMONABANT; SECRETASE; TAU PROTEIN; TRANSCRIPTOME; UBIQUITIN; UBIQUITIN CONJUGATING ENZYME E2; VANILLOID RECEPTOR 2; TRPV1 PROTEIN, HUMAN; VANILLOID RECEPTOR;

ALZHEIMER DISEASE; ARTICLE; CONTROLLED STUDY; DNA TRANSCRIPTION; DOWN REGULATION; GENE EXPRESSION; GENE EXPRESSION PROFILING; GENE INACTIVATION; GINGIVAL BIOPSY; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOCYTOCHEMISTRY; MESENCHYMAL STEM CELL; NEUROFIBRILLARY TANGLE; NEXT GENERATION SEQUENCING; NORMAL HUMAN; POLYMERASE CHAIN REACTION; PROTEIN EXPRESSION; PROTEIN INTERACTION; SCANNING ELECTRON MICROSCOPY; SEQUENCE ANALYSIS; TRANSCRIPTION REGULATION; UBIQUITINATION; CELL CULTURE; DRUG EFFECTS; GENETICS; MALE; MESENCHYMAL STROMA CELL; METABOLISM;

ALZHEIMER DISEASE; AMYLOID BETA-PEPTIDES; CANNABIDIOL; CELLS, CULTURED; GLYCOGEN SYNTHASE KINASE 3 BETA; HUMANS; MALE; MESENCHYMAL STROMAL CELLS; PHOSPHATIDYLINOSITOL 3-KINASES; PROTO-ONCOGENE PROTEINS C-AKT; TAU PROTEINS; TRANSCRIPTOME; TRPV CATION CHANNELS;

EID: 85016924311     PISSN: 16616596     EISSN: 14220067     Source Type: Journal    
DOI: 10.3390/ijms18010026     Document Type: Article

References (52)

1. Du, L.; Yang, P.; Ge, S. Isolation and characterization of human gingiva-derived mesenchymal stem cells using limiting dilution method. J. Dent. Sci. 2016, 11, 304-314. [CrossRef]
2. Gao, Y.; Zhao, G.; Li, D.; Chen, X.; Pang, J.; Ke, J. Isolation and multiple differentiation potential assessment of human gingival mesenchymal stem cells. Int. J. Mol. Sci. 2014, 15, 20982-20996. [CrossRef] [PubMed]
3. Mitrano, T.I.; Grob, M.S.; Carrion, F.; Nova-Lamperti, E.; Luz, P.A.; Fierro, F.S.; Quintero, A.; Chaparro, A.; Sanz, A. Culture and characterization of mesenchymal stem cells from human gingival tissue. J. Periodontol. 2010, 81, 917-925. [CrossRef] [PubMed]
4. Hass, R.; Kasper, C.; Bohm, S.; Jacobs, R. Different populations and sources of human mesenchymal stem cells (MSC): A comparison of adult and neonatal tissue-derived MSC. Cell Commun. Signal. 2011, 9, 12. [CrossRef] [PubMed]
5. Santamaria, S.; Sanchez, N.; Sanz, M.; Garcia-Sanz, J.A. Comparison of periodontal ligament and gingiva-derived mesenchymal stem cells for regenerative therapies. Clin. Oral Investig. 2016. [CrossRef] [PubMed]
6. Tomar, G.B.; Srivastava, R.K.; Gupta, N.; Barhanpurkar, A.P.; Pote, S.T.; Jhaveri, H.M.; Mishra, G.C.;Wani,M.R. Human gingiva-derived mesenchymal stem cells are superior to bone marrow-derived mesenchymal stem cells for cell therapy in regenerative medicine. Biochem. Biophys. Res. Commun. 2010, 393, 377-383. [CrossRef] [PubMed]
7. Xu, X.; Chen, C.; Akiyama, K.; Chai, Y.; Le, A.D.; Wang, Z.; Shi, S. Gingivae contain neural-crest- and mesoderm-derived mesenchymal stem cells. J. Dent. Res. 2013, 92, 825-832. [CrossRef] [PubMed]
8. Gouras, G.K.; Almeida, C.G.; Takahashi, R.H. Intraneuronal Aβ accumulation and origin of plaques in Alzheimer’s disease. Neurobiol. Aging 2005, 26, 1235-1244. [CrossRef] [PubMed]
9. Selkoe, D.J. Alzheimer’s disease results from the cerebral accumulation and cytotoxicity of amyloid β-protein. J. Alzheimers Dis. 2001, 3, 75-80. [PubMed]
10. Chow, V.W.; Mattson, M.P.; Wong, P.C.; Gleichmann, M. An overview of APP processing enzymes and products. Neuromol. Med. 2010, 12, 1-12. [CrossRef] [PubMed]
11. Cruchaga, C.; Haller, G.; Chakraverty, S.; Mayo, K.; Vallania, F.L.M.; Mitra, R.D.; Faber, K.;Williamson, J.; Bird, T.; Diaz-Arrastia, R.; et al. NIA-LOAD/NCRAD family study consortium rare variants in APP, PSEN1 and PSEN2 increase risk for AD in late-onset Alzheimer’s disease families. PLoS ONE 2012, 7, e31039. [CrossRef]
12. Dolan, P.J.; Johnson, G.V.W. The role of tau kinases in Alzheimer’s disease. Curr. Opin. Drug Discov. Dev. 2010, 13, 595-603.
13. Ferrer, I.; Barrachina, M.; Puig, B.; Martinez de Lagran, M.; Marti, E.; Avila, J.; Dierssen, M. Constitutive Dyrk1A is abnormally expressed in Alzheimer disease, Down syndrome, Pick disease, and related transgenic models. Neurobiol. Dis. 2005, 20, 392-400. [CrossRef] [PubMed]
14. 2+/calmodulin-dependent protein kinase II as demonstrated tandem mass spectrometry. Neurosci. Lett. 2003, 353, 185-188. [CrossRef] [PubMed]
15. Esposito, G.; de Filippis, D.; Carnuccio, R.; Izzo, A.A.; Iuvone, T. The marijuana component cannabidiol inhibits β-amyloid-induced tau protein hyperphosphorylation through Wnt/β-catenin pathway rescue in PC12 cells. J. Mol. Med. (Berl.) 2006, 84, 253-258. [CrossRef] [PubMed]
16. Scuderi, C.; Steardo, L.; Esposito, G. Cannabidiol promotes amyloid precursor protein ubiquitination and reduction of β amyloid expression in SHSY5YAPP+ cells through PPARγ involvement. Phytother. Res. 2014, 28, 1007-1013. [CrossRef] [PubMed]
17. Cheng, D.; Low, J.K.; Logge,W.; Garner, B.; Karl, T. Chronic cannabidiol treatment improves social and object recognition in double transgenic APPswe/PS1DE9 mice. Psychopharmacology (Berl.) 2014, 231, 3009-3017. [CrossRef] [PubMed]
18. Fawzy El-Sayed, K.M.; Dorfer, C.E. Gingival Mesenchymal Stem/Progenitor Cells: A Unique Tissue Engineering Gem. Stem Cells Int. 2016, 2016, 7154327. [CrossRef] [PubMed]
19. Dominici, M.; Le Blanc, K.; Mueller, I.; Slaper-Cortenbach, I.; Marini, F.; Krause, D.; Deans, R.; Keating, A.; Prockop, D.; Horwitz, E.Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement. Cytotherapy 2006, 8, 315-317. [CrossRef] [PubMed]
20. Lee, J.K.; Schuchman, E.H.; Jin, H.K.; Bae, J. Soluble CCL5 derived from bone marrow-derived mesenchymal stem cells and activated by amyloid β ameliorates Alzheimer’s disease in mice by recruiting bone marrow-induced microglia immune responses. Stem Cells 2012, 30, 1544-1555. [CrossRef] [PubMed]
21. Lee, H.J.; Lee, J.K.; Lee, H.; Carter, J.E.; Chang, J.W.; Oh, W.; Yang, Y.S.; Suh, J.-G.; Lee, B.-H.; Jin, H.K.; et al. Human umbilical cord blood-derived mesenchymal stem cells improve neuropathology and cognitive impairment in an Alzheimer’s disease mouse model through modulation of neuroinflammation. Neurobiol. Aging 2012, 33, 588-602. [CrossRef] [PubMed]
22. Juknat, A.; Rimmerman, N.; Levy, R.; Vogel, Z.; Kozela, E. Cannabidiol affects the expression of genes involved in zinc homeostasis in BV-2 microglial cells. Neurochem. Int. 2012, 61, 923-930. [CrossRef] [PubMed]
23. Hooper, C.; Killick, R.; Lovestone, S. The GSK3 hypothesis of Alzheimer’s disease. J. Neurochem. 2008, 104, 1433-1439. [CrossRef] [PubMed]
24. Noble, W.; Olm, V.; Takata, K.; Casey, E.; Mary, O.; Meyerson, J.; Gaynor, K.; LaFrancois, J.; Wang, L.; Kondo, T.; et al. CDK5 is a key factor in tau aggregation and tangle formation in vivo. Neuron 2003, 38, 555-565. [CrossRef]
25. Ryoo, S.-R.; Jeong, H.K.; Radnaabazar, C.; Yoo, J.-J.; Cho, H.-J.; Lee, H.-W.; Kim, I.-S.; Cheon, Y.-H.; Ahn, Y.S.; Chung, S.-H.; et al. DYRK1A-mediated hyperphosphorylation of Tau. A functional link between Down syndrome and Alzheimer disease. J. Biol. Chem. 2007, 282, 34850-34857. [CrossRef] [PubMed]
26. 2+/calmodulin-dependent protein kinase II in neuronal soma in brain. J. Neurochem. 2005, 94, 1438-1447. [CrossRef] [PubMed]
27. Goedert,M.;Hasegawa,M.; Jakes, R.; Lawler, S.; Cuenda,A.; Cohen, P. Phosphorylation ofmicrotubule-associated protein tau by stress-activated protein kinases. FEBS Lett. 1997, 409, 57-62. [CrossRef]
28. Tsai, L.-H.; Patrick, G.N.; Zukerberg, L.; Nikolic, M.; de la Monte, S.; Dikkes, P. Conversion of p35 to p25 deregulates CDK5 activity and promotes neurodegeneration. Nature 1999, 402, 615-622. [CrossRef] [PubMed]
29. Chen, J.; Li, H.; Feng, Y.; Wang, J. The effect of CDK-5 overexpression and overactivation on tau hyperphosphorylation in cultured N2a cells. Wuhan Univ. J. Nat. Sci. 2005, 10, 472-476.
30. Bukau, B.; Weissman, J.; Horwich, A. Molecular chaperones and protein quality control. Cell 2006, 125, 443-451. [CrossRef] [PubMed]
31. Hong, L.; Huang, H.-C.; Jiang, Z.-F. Relationship between amyloid-β and the ubiquitin-proteasome system in Alzheimer’s disease. Neurol. Res. 2014, 36, 276-282. [CrossRef] [PubMed]
32. Gadhave, K.; Bolshette, N.; Ahire, A.; Pardeshi, R.; Thakur, K.; Trandafir, C.; Istrate, A.; Ahmed, S.; Lahkar, M.; Muresanu, D.F.; et al. The ubiquitin proteasomal system: A potential target for the management of Alzheimer’s disease. J. Cell. Mol. Med. 2016, 20, 1392-1407. [CrossRef] [PubMed]
33. Patterson, K.R.; Ward, S.M.; Combs, B.; Voss, K.; Kanaan, N.M.; Morfini, G.; Brady, S.T.; Gamblin, T.C.; Binder, L.I. Heat shock protein 70 prevents both tau aggregation and the inhibitory effects of preexisting tau aggregates on fast axonal transport. Biochemistry 2011, 50, 10300-10310. [CrossRef] [PubMed]
34. Ou, J.-R.; Tan, M.-S.; Xie, A.-M.; Yu, J.-T.; Tan, L. Heat shock protein 90 in Alzheimer’s Disease. BioMed Res. Int. 2014, 2014, 1-7. [CrossRef] [PubMed]
35. Hernandez, F.; Gomez de Barreda, E.; Fuster-Matanzo, A.; Lucas, J.J.; Avila, J. GSK3: A possible link between β amyloid peptide and tau protein. Exp. Neurol. 2010, 223, 322-325. [CrossRef] [PubMed]
36. Trazzi, S.; Steger, M.; Mitrugno, V.M.; Bartesaghi, R.; Ciani, E. CB1 cannabinoid receptors increase neuronal precursor proliferation through AKT/glycogen synthase kinase-3β/β-catenin signaling. J. Biol. Chem. 2010, 285, 10098-10109. [CrossRef] [PubMed]
37. Ozaita, A.; Puighermanal, E.; Maldonado, R. Regulation of PI3K/Akt/GSK-3 pathway by cannabinoids in the brain. J. Neurochem. 2007, 102, 1105-1114. [CrossRef] [PubMed]
38. Iannotti, F.A.; Hill, C.L.; Leo, A.; Alhusaini, A.; Soubrane, C.; Mazzarella, E.; Russo, E.; Whalley, B.J.; di Marzo, V.; Stephens, G.J. Nonpsychotropic plant cannabinoids, cannabidivarin (CBDV) and cannabidiol (CBD), activate and desensitize transient receptor potential vanilloid 1 (TRPV1) channels in vitro: Potential for the treatment of neuronal hyperexcitability. ACS Chem. Neurosci. 2014, 5, 1131-1141. [CrossRef] [PubMed]
39. Trubiani, O.; Guarnieri, S.; Diomede, F.; Mariggio, M.A.; Merciaro, I.; Morabito, C.; Cavalcanti, M.F.X.B.; Cocco, L.; Ramazzotti, G. Nuclear translocation of PKCα isoenzyme is involved in neurogenic commitment of human neural crest-derived periodontal ligament stem cells. Cell Signal. 2016, 28, 1631-1641. [CrossRef] [PubMed]
40. Bisogno, T.; Hanus, L.; de Petrocellis, L.; Tchilibon, S.; Ponde, D.E.; Brandi, I.; Moriello, A.S.; Davis, J.B.; Mechoulam, R.; di Marzo, V. Molecular targets for cannabidiol and its synthetic analogues: Effect on vanilloid VR1 receptors and on the cellular uptake and enzymatic hydrolysis of anandamide. Br. J. Pharmacol. 2001, 134, 845-852. [CrossRef] [PubMed]
41. Hassan, S.; Eldeeb, K.; Millns, P.J.; Bennett, A.J.; Alexander, S.P.H.; Kendall, D.A. Cannabidiol enhances microglial phagocytosis via transient receptor potential (TRP) channel activation. Br. J. Pharmacol. 2014, 171, 2426-2439. [CrossRef] [PubMed]
42. Stein, A.T.; Ufret-Vincenty, C.A.; Hua, L.; Santana, L.F.; Gordon, S.E. Phosphoinositide 3-kinase binds to TRPV1 and mediates NGF-stimulated TRPV1 trafficking to the plasma membrane. J. Gen. Physiol. 2006, 128, 509-522. [CrossRef] [PubMed]
43. Taglialatela-Scafati, O.; Pagani, A.; Scala, F.; De Petrocellis, L.; Di Marzo, V.; Grassi, G.; Appendino, G. Cannabimovone, a cannabinoid with a rearranged terpenoid skeleton from hemp. Eur. J. Org. Chem. 2010, 2010, 2067-2072. [CrossRef]
44. Diomede, F.; Caputi, S.; Merciaro, I.; Frisone, S.; D’Arcangelo, C.; Piattelli, A.; Trubiani, O. Pro-inflammatory cytokine release and cell growth inhibition in primary human oral cells after exposure to endodontic sealer. Int. Endod. J. 2014, 47, 864-872. [CrossRef] [PubMed]
45. Diomede, F.; Zini, N.; Gatta, V.; Fulle, S.; Merciaro, I.; D’Aurora, M.; La Rovere, R.M.; Traini, T.; Pizzicannella, J.; Ballerini, P.; et al. Human periodontal ligament stem cells cultured onto cortico-cancellous scaffold drive bone regenerative process. Eur. Cell Mater. 2016, 32, 181-201. [CrossRef] [PubMed]
46. Rajan, T.S.; Giacoppo, S.; Scionti, D.; Diomede, F.; Grassi, G.; Pollastro, F.; Piattelli, A.; Bramanti, P.; Mazzon, E.; Trubiani, O. Cannabidiol activates neuronal precursor genes in human gingival mesenchymal stromal cells. J. Cell. Biochem. 2016. [CrossRef] [PubMed]
47. Kim, S.H.;Won, S.J.; Mao, X.O.; Jin, K.; Greenberg, D.A. Involvement of protein kinase A in Cannabinoid receptor-mediated protection from oxidative neuronal injury. J. Pharmacol. Exp. Ther. 2005, 313, 88-94. [CrossRef] [PubMed]
48. Whalley, B.J.; Wilkinson, J.D.; Williamson, E.M.; Constanti, A. A novel component of cannabis extract potentiates excitatory synaptic transmission in rat olfactory cortex in vitro. Neurosci. Lett. 2004, 365, 58-63. [CrossRef] [PubMed]
49. Ambrosino, P.; Soldovieri, M.V.; Russo, C.; Taglialatela, M. Activation and desensitization of TRPV1 channels in sensory neurons by the PPARα agonist palmitoylethanolamide. Br. J. Pharmacol. 2013, 168, 1430-1444. [CrossRef] [PubMed]
50. Kwak, J. Capsaicin blocks the hyperpolarization-activated inward currents via TRPV1 in the rat dorsal root ganglion neurons. Exp. Neurobiol. 2012, 21, 75-82. [CrossRef] [PubMed]
51. Geng, D.C.; Xu, Y.Z.; Yang, H.L.; Zhu, X.S.; Zhu, G.M.;Wang, X.B. Inhibition of titanium particle-induced inflammatory osteolysis through inactivation of cannabinoid receptor 2 by AM630. J. Biomed. Mater. Res. Part A 2010, 95A, 321-326. [CrossRef] [PubMed]
52. 2+exchanger current in rat cardiac myocytes. PLoS ONE 2013, 8, e63386. [CrossRef] [PubMed]